Filter:
Nucleus Network Acquires Hammersmith Medicines Research
First Truly Global Early-Phase Clinical Trial Network Brisbane, Australia and London, U.K....
Published: 4th August 2025
Read more
Nucleus Network MSP: A global leader in renal clinical trials
Renal impairment trials demand precision, speed, and a deep understanding of the...
Published: 4th July 2025
Why sponsors choose Nucleus Network: A 3-year performance overview
From biotech startups to global pharma, early-phase sponsors continue to trust Nucleus...
Published: 3rd July 2025
Gap analysis and clinical services to strengthen your study design
Moving from preclinical studies to first-in-human (FIH) trials is a pivotal step...
The future of strategic medicine: The impact and promise of RNA drugs white paper
RNA drugs are transforming modern medicine, offering groundbreaking solutions for genetic disorders,...
Global reach, Early-Phase focus: Nucleus Network’s capabilities
In early clinical development, speed and precision are everything. Nucleus Network delivers...
Wrapping Up BIO 2025: Real Conversations, Global Momentum
That’s a wrap on BIO 2025 and what a week it was....
Published: 27th June 2025
